InvestorsObserver is giving Rigel Pharmaceuticals Inc (RIGL) an Analyst Rating Rank of 33, meaning RIGL is ranked higher by analysts than 33% of stocks. The average price target for RIGL is $3.492 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating RIGL a Buy today. Find out what this means to you and get the rest of the rankings on RIGL!